A股異動丨青青稞酒(002646.SZ)跌近6% 股東紛紛減持
格隆匯11月25日丨青青稞酒(002646.SZ)低開低走,現跌近6%,報17.55元,總市值79億元。本週一青青稞酒(002646.SZ)股價一度刷新逾三年來新高。青青稞酒昨日公佈,近日,公司收到控股股東華實投資《關於股份減持計劃進展的告知函》,華實投資自2020年8月25日至2020年11月23日通過集中競價交易方式累計減持公司股份481.88萬股,佔公司總股本的1.0708%。此外,截至2020年11月19日,控股股東減持時間已過半,華實投資自2020年8月25日至2020年11月19日通過集中競價交易方式累計減持公司股份449.58萬股,佔公司總股本的0.9991%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.